# Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis

> **NCT07083063** · PHASE4 · RECRUITING · sponsor: **National Cheng-Kung University Hospital** · enrollment: 440 (estimated)

## Conditions studied

- Pancreatitis

## Interventions

- **DRUG:** Nitroglycerin (NTG)
- **DRUG:** Normal Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07083063
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07083063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07083063, "Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07083063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*